Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.

Jennifer SassonAlexandra N DonlanJennie Z MaHeather M HaugheyRachael ColemanUma NayakAmy J MathersSylvain LaverdureRobin DewarPatrick E H JacksonScott K HeysellJeffrey M SturekWilliam A Petri

Published in: medRxiv : the preprint server for health sciences (2022)

Virginia Biosciences Health Research Corporation, PBM C19, Henske Family Foundation, National Institutes of Health, National Cancer Institute.

Keyphrases

coronavirus disease
sars cov
healthcare
public health
mental health
clinical trial
early onset
study protocol
atopic dermatitis
phase iii
phase ii
health information
social media
placebo controlled